Advanced Temperature Controller for Microfluidic Devices for Biotech Research Introduced

By LabMedica International staff writers
Posted on 01 Oct 2014
An innovative temperature controller for use in microfluidic applications is available for use by biotech and other life science researchers.

The microfluidics specialty company Dolomite (Royston, United Kingdom) introduced its new Meros TCU-100 temperature controller at the September 18–19, 2014, Lab-on-a-Chip & Microarray World Congress held in San Diego (CA, USA).

Image: The new Meros TCU-100 temperature controller (Photo courtesy of Dolomite).

The Meros TCU-100 is the first module in the company's new Meros range of plug-and-play microfluidic products. This line consists of a suite of integrated tools, specifically targeted at microfluidics users in research and education, with the ambition of providing a sophisticated suite of intelligently coordinated capabilities. The suite is be based around a modern touch-screen interface enabling clear visualization of data and virtual reconfiguration of the connected hardware such as pumps and valves. The intuitive and easy to use connections to microfluidic devices is be based on Dolomite’s existing range of microfluidic connectors, Multiflux.

The new Meros TCU-100 temperature controller, which offers advanced temperature control from 1–100 °C, was designed to accommodate a wide range of biological and chemical applications, including cell analysis, thermal control of microreactors, incubation of microdroplets, protein crystallization, nanoparticle synthesis, and thermocycling of micro-scale samples. The instrument is accurate within 0.5 °C with stability and target temperature resolution of 0.1 °C and rapid ramp rates up to 1 °C per second. Operation, data logging, and graphical data display are achieved through Dolomite’s user-friendly Flow Control Center software or third-party software.

“At Dolomite, we believe the scientist should be free to focus on science and not have to worry about finding the right tools for their job. That is why we will provide researchers with a next generation of plug and play microfluidic platforms for use in the laboratory,” said Andrew Lovatt, CEO of Dolomite. “Once again, Dolomite will apply its world-leading expertise in microfluidic solutions to development of innovative technologies.”

Related Links:

Dolomite



Latest BioResearch News